Riemekasten G, et al: A novel epitope on the C-terminus of SmD1 is recognized by the majority of sera from patients with systemic lupus erythematosus. J Clin Invest. 1998, 102: 754-763.
Riemekasten G, et al: T cell reactivity against the SmD1(83-119) C terminal peptide in patients with systemic lupus erythematosus. Ann Rheum Dis. 2002, 61: 779-785. 10.1136/ard.61.9.779.
Riemekasten G, et al: Identification and characterization of SmD183-119-reactive T cells that provide T cell help for pathogenic anti-double-stranded DNA antibodies. Arthritis Rheum. 2003, 48: 475-485. 10.1002/art.10762.
Riemekasten G, Langnickel D, et al: Intravenous injection of a D1 protein of the smith proteins postpones murine lupus and induces type 1 regulatory T cells. J Immunol. 2004, 173: 5835-5842.